Coastal Investment Advisors, Inc. Insmed Inc Transaction History

Coastal Investment Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 23, 2020	SELL	$13.63 - $33.98 $28,364 - $70,712	-2,081 Closed	0 $0
Q3 2019 Oct 18, 2019	BUY	$15.49 - $25.78 $7,977 - $13,276	515 Added 32.89%	2,081 $37,000
Q1 2019 May 15, 2019	BUY	$13.91 - $31.15 $21,783 - $48,780	1,566 New	1,566 $45,000

465

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $8.98B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.